1. Home
  2. SQNS vs RVPH Comparison

SQNS vs RVPH Comparison

Compare SQNS & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SQNS
  • RVPH
  • Stock Information
  • Founded
  • SQNS 2003
  • RVPH 2006
  • Country
  • SQNS France
  • RVPH United States
  • Employees
  • SQNS N/A
  • RVPH N/A
  • Industry
  • SQNS Semiconductors
  • RVPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • SQNS Technology
  • RVPH Health Care
  • Exchange
  • SQNS Nasdaq
  • RVPH Nasdaq
  • Market Cap
  • SQNS 85.7M
  • RVPH 88.0M
  • IPO Year
  • SQNS 2011
  • RVPH N/A
  • Fundamental
  • Price
  • SQNS $3.19
  • RVPH $2.07
  • Analyst Decision
  • SQNS Strong Buy
  • RVPH Strong Buy
  • Analyst Count
  • SQNS 1
  • RVPH 5
  • Target Price
  • SQNS $7.50
  • RVPH $11.40
  • AVG Volume (30 Days)
  • SQNS 118.6K
  • RVPH 2.1M
  • Earning Date
  • SQNS 02-11-2025
  • RVPH 11-14-2024
  • Dividend Yield
  • SQNS N/A
  • RVPH N/A
  • EPS Growth
  • SQNS N/A
  • RVPH N/A
  • EPS
  • SQNS 1.65
  • RVPH N/A
  • Revenue
  • SQNS $30,555,000.00
  • RVPH N/A
  • Revenue This Year
  • SQNS $10.14
  • RVPH N/A
  • Revenue Next Year
  • SQNS $8.54
  • RVPH N/A
  • P/E Ratio
  • SQNS $1.99
  • RVPH N/A
  • Revenue Growth
  • SQNS N/A
  • RVPH N/A
  • 52 Week Low
  • SQNS $0.85
  • RVPH $0.60
  • 52 Week High
  • SQNS $7.43
  • RVPH $4.83
  • Technical
  • Relative Strength Index (RSI)
  • SQNS 50.30
  • RVPH 59.47
  • Support Level
  • SQNS $3.00
  • RVPH $1.78
  • Resistance Level
  • SQNS $3.64
  • RVPH $1.91
  • Average True Range (ATR)
  • SQNS 0.22
  • RVPH 0.16
  • MACD
  • SQNS -0.01
  • RVPH 0.01
  • Stochastic Oscillator
  • SQNS 34.78
  • RVPH 82.98

About SQNS Sequans Communications S.A.

Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its solutions incorporate baseband processor and radio frequency, transceiver integrated circuits, along with its proprietary signal processing techniques, algorithms, and software stacks. The company's solutions serve as the core wireless broadband communications platform in devices, including smartphones, USB dongles, portable routers, laptops, netbooks, tablets, and other consumer multimedia and industrial devices. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.

Share on Social Networks: